AV

Adarsh Valmiki

Active Director Director DIN 09793682
DIN 09793682 First appointment Nov 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Adarsh Valmiki

Data last updated:

Adarsh Valmiki is a Director at Meropy Pharmaceuticals India Private Limited (since 2022). The company operates in Chemicals.

DIN 09793682
Primary Designation Director
Industry Chemicals
First Appointment 17 Nov 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Nov 20222022Active

Board colleagues of Adarsh Valmiki

NameDINCompanyDesignation
Raj Verma09793681Meropy Pharmaceuticals India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Meropy Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Adarsh Valmiki

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Adarsh Valmiki

Adarsh Valmiki currently holds 1 directorship: Meropy Pharmaceuticals India Private Limited (Director, since 17 Nov 2022).

Adarsh Valmiki was first appointed on 17 Nov 2022 as Director at Meropy Pharmaceuticals India Private Limited.

The current boards of Adarsh Valmiki's companies include Raj Verma (Meropy Pharmaceuticals India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available